{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:20:34Z","timestamp":1789017634058,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ackdjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1053\/j.ackd.2021.09.001","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T12:03:31Z","timestamp":1645185811000},"page":"490-501.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Late Kidney Effects of Childhood Cancer and Cancer Therapies"],"prefix":"10.1053","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1505-7424","authenticated-orcid":false,"given":"Brian R.","family":"Stotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Chanchlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1053\/j.ackd.2021.09.001_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)","volume":"238","author":"Farber","year":"1948","journal-title":"New Engl J Med"},{"issue":"15","key":"10.1053\/j.ackd.2021.09.001_bib2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"New Engl J Med"},{"issue":"12","key":"10.1053\/j.ackd.2021.09.001_bib3","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S1470-2045(18)30537-0","article-title":"Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970\u201399: a report from the Childhood Cancer Survivor Study cohort","volume":"19","author":"Gibson","year":"2018","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11523-015-0368-7","article-title":"Renal toxicities of targeted therapies","volume":"10","author":"Abbas","year":"2015","journal-title":"Target Oncol"},{"issue":"6","key":"10.1053\/j.ackd.2021.09.001_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1080\/17512433.2019.1613888","article-title":"The nephrotoxicity of new immunotherapies","volume":"12","author":"Sury","year":"2019","journal-title":"Expert Rev Clin Phar"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/petr.12935","article-title":"Hematopoietic stem cell transplantation and acute kidney injury in children: a comprehensive review","volume":"21","author":"Raina","year":"2017","journal-title":"Pediatr Transpl"},{"issue":"12","key":"10.1053\/j.ackd.2021.09.001_bib7","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/bcp.13388","article-title":"Renal toxicity and chemotherapy in children with cancer","volume":"83","author":"Ruggiero","year":"2017","journal-title":"Br J Clin Pharmaco"},{"issue":"1","key":"10.1053\/j.ackd.2021.09.001_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/PL00006741","article-title":"Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines","volume":"45","author":"Kr\u00f6ning","year":"2000","journal-title":"Cancer Chemoth Pharm"},{"issue":"9","key":"10.1053\/j.ackd.2021.09.001_bib9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00467-017-3765-6","article-title":"Identifying cisplatin-induced kidney damage in paediatric oncology patients","volume":"33","author":"Barton","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3476(05)83372-4","article-title":"Partial reversibility of cisplatin nephrotoxicity in children","volume":"118","author":"Brock","year":"1991","journal-title":"J Pediatr"},{"issue":"1","key":"10.1053\/j.ackd.2021.09.001_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","article-title":"Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis","volume":"28","author":"Ariceta","year":"1997","journal-title":"Med Pediatr Oncol"},{"issue":"3","key":"10.1053\/j.ackd.2021.09.001_bib12","first-page":"CD008944","article-title":"Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer","volume":"3","author":"Kooijmans","year":"2019","journal-title":"Cochrane Db Syst Rev"},{"issue":"18","key":"10.1053\/j.ackd.2021.09.001_bib13","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1016\/j.ejca.2009.06.032","article-title":"Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: Relevance of age and dose as risk factors","volume":"45","author":"Skinner","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1053\/j.ackd.2021.09.001_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/pbc.20812","article-title":"Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the late effects surveillance system","volume":"48","author":"St\u00f6hr","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1053\/j.ackd.2021.09.001_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00381-016-3130-2","article-title":"Renal function in children treated for central nervous system malignancies","volume":"32","author":"Musiol","year":"2016","journal-title":"Child\u2019s Nerv Syst"},{"issue":"12","key":"10.1053\/j.ackd.2021.09.001_bib16","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-018-3976-5","article-title":"Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study","volume":"33","author":"McMahon","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2021.09.001_bib17","first-page":"1457","article-title":"Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy","volume":"47","author":"Goren","year":"1987","journal-title":"Cancer Res"},{"issue":"1","key":"10.1053\/j.ackd.2021.09.001_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1200\/JCO.1994.12.1.159","article-title":"Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients","volume":"12","author":"Rossi","year":"1994","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1053\/j.ackd.2021.09.001_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1517\/14740330902808169","article-title":"Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention","volume":"8","author":"Hanly","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib20","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/pbc.20858","article-title":"Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System","volume":"48","author":"St\u00f6hr","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1053\/j.ackd.2021.09.001_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/(SICI)1096-911X(199903)32:3<177::AID-MPO3>3.0.CO;2-H","article-title":"Development of ifosfamide-induced nephrotoxicity: prospective follow-up in 75 patients","volume":"32","author":"Rossi","year":"1999","journal-title":"Med Pediatr Oncol"},{"issue":"32","key":"10.1053\/j.ackd.2021.09.001_bib22","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1200\/JCO.2008.17.5257","article-title":"Long-term evaluation of ifosfamide-related nephrotoxicity in children","volume":"27","author":"Oberlin","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1053\/j.ackd.2021.09.001_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2215\/CJN.12101112","article-title":"Nephrology for the AKIAG of the as of. AKI Transition of care: a potential Opportunity to detect and prevent CKD","volume":"8","author":"Goldstein","year":"2013","journal-title":"Clin J Am Soc Nephro"},{"issue":"9","key":"10.1053\/j.ackd.2021.09.001_bib24","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2215\/CJN.08250718","article-title":"Secular trends in incidence, modality and mortality with dialysis receiving AKI in children in Ontario: a population-based cohort study","volume":"14","author":"Chanchlani","year":"2019","journal-title":"Clin J Am Soc Nephro"},{"issue":"10","key":"10.1053\/j.ackd.2021.09.001_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1055-9965.EPI-13-0036","article-title":"Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study","volume":"22","author":"Mulder","year":"2013","journal-title":"Cancer Epidemiol Prev Biomarkers"},{"issue":"9","key":"10.1053\/j.ackd.2021.09.001_bib26","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2215\/CJN.09620911","article-title":"Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors","volume":"7","author":"Knijnenburg","year":"2012","journal-title":"Clin J Am Soc Nephro"},{"issue":"11","key":"10.1053\/j.ackd.2021.09.001_bib27","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-018-4085-1","article-title":"Towards adulthood with a solitary kidney","volume":"34","author":"Cochat","year":"2019","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2021.09.001_bib28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0270-9295(03)00093-7","article-title":"Radiation nephropathy","volume":"23","author":"Cohen","year":"2003","journal-title":"Semin Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2021.09.001_bib29","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00467-017-3673-9","article-title":"Prospective analysis of long-term renal function in survivors of childhood Wilms tumor","volume":"32","author":"Neu","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2021.09.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.28271","article-title":"Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study","volume":"67","author":"Green","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.ackd.2021.09.001_bib31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jpeds.2020.12.005","article-title":"Kidney outcomes and hypertension in survivors of Wilms tumor: a prospective cohort study","volume":"230","author":"Chu","year":"2021","journal-title":"J Pediatr"},{"issue":"6","key":"10.1053\/j.ackd.2021.09.001_bib32","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/pbc.21695","article-title":"Renal late effects in patients treated for cancer in childhood: a report from the Children\u2019s\u00a0Oncology Group","volume":"51","author":"Jones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1053\/j.ackd.2021.09.001_bib33","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2215\/CJN.09980912","article-title":"Long-term nephrotoxicity in adult survivors of childhood cancer","volume":"8","author":"Dekkers","year":"2013","journal-title":"Clin J Am Soc Nephro"},{"issue":"10","key":"10.1053\/j.ackd.2021.09.001_bib34","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/aje\/kwn033","article-title":"Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population","volume":"167","author":"Astor","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1053\/j.ackd.2021.09.001_bib35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/ki.1996.265","article-title":"The hyperfiltration theory: a paradigm shift in nephrology","volume":"49","author":"Brenner","year":"1996","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2021.09.001_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/pbc.25897","article-title":"Yield of urinalysis screening in pediatric cancer survivors","volume":"63","author":"Ramirez","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1681\/ASN.2020060849","article-title":"Kidney function after treatment for childhood cancer: a report from the St. Jude Lifetime cohort study","volume":"32","author":"Green","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2021.09.001_bib38","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.24829","article-title":"Signs of early sub-clinical atherosclerosis in childhood cancer survivors","volume":"61","author":"Dengel","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1053\/j.ackd.2021.09.001_bib39","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/pbc.25547","article-title":"Arterial stiffness in childhood cancer survivors","volume":"62","author":"Krystal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"29","key":"10.1053\/j.ackd.2021.09.001_bib40","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8229","key":"10.1053\/j.ackd.2021.09.001_bib41","first-page":"1","article-title":"Major cardiac events for adult survivors of childhood cancer diagnosed between 1970 and 1999: report from the Childhood Cancer Survivor Study cohort","volume":"368","author":"Mulrooney","year":"2020","journal-title":"Bmj"},{"issue":"1","key":"10.1053\/j.ackd.2021.09.001_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jpedsurg.2016.10.027","article-title":"Comprehensive renal function evaluation in patients treated for synchronous bilateral Wilms tumor","volume":"52","author":"Interiano","year":"2017","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib43","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ejca.2010.01.002","article-title":"Hypertension in long-term survivors of childhood cancer: a nested case-control study","volume":"46","author":"Cardous-Ubbink","year":"2010","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib44","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Tr"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib45","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/pbc.22518","article-title":"Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy","volume":"55","author":"Geenen","year":"2010","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1053\/j.ackd.2021.09.001_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"10.1053\/j.ackd.2021.09.001_bib47","author":"Skinner"},{"issue":"4","key":"10.1053\/j.ackd.2021.09.001_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/pbc.24445","article-title":"A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the international late effects of Childhood Cancer Guideline Harmonization Group","volume":"60","author":"Kremer","year":"2013","journal-title":"Pediatr Blood Cancer"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559521000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559521000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:03:17Z","timestamp":1761548597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559521000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1548559521000902"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2021.09.001","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Late Kidney Effects of Childhood Cancer and Cancer Therapies","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2021.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}